Genetically modified paramyxovirus for treatment of tumor diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9821016
SERIAL NO

13656913

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a genetically modified Paramyxovirus, a pharmaceutical composition comprising this paramyxovirus, the use of a genetically modified Paramyxovirus for the therapeutic and/or prophylactic treatment of a tumor disease, and a method for the production of a pharmaceutical composition for the therapeutic or prophylactic treatment of a tumor disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUMGEISSWEG 3 72076 TUEBINGEN 72076

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armeanu-Ebinger, Sorin Tuebingen, DE 4 11
Bitzer, Michael Rottenburg, DE 4 1
Bossow, Sascha Heidelberg, DE 10 19
Lauer, Ulrich Manfred Tuebingen, DE 1 1
Neubert, Wolfgang Greifenberg, DE 3 16
Zimmermann, Martina Tuebingen, DE 3 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00